Diabetic Cardiomyopathy: baseline Characteristics of patients enrolled into the ARISE-HF trial

被引：0
|
作者：
Del Prato, S. [1 ]
Rosenstock, J. [2 ]
Butler, J. [3 ]
Ezekowitz, J. [4 ]
Ibrahim, N. [5 ]
Lam, C. [6 ]
Marwick, T. [7 ]
Perfetti, R. [8 ]
Tang, W. H. Wilson [9 ]
Urbinati, A. Alessia [8 ]
Zannad, F. [10 ]
Januzzi, J. [11 ]
机构：
[1] Univ Pisa, Pisa, Italy
[2] Dallas Diabet Res Ctr, Dallas, TX USA
[3] Baylor Scott & White Hlth, Dallas, TX USA
[4] Univ Alberta, Edmonton, AB, Canada
[5] Harvard TH Chan Sch Publ Hlth, Boston, MA USA
[6] Duke NUS Grad Med Sch Singapore, Singapore, Singapore
[7] Baker Heart & Diabet Inst, Melbourne, Australia
[8] Appl Therapeut, New York, NY USA
[9] Cleveland Clin, Cleveland, OH USA
[10] Univ Lorraine, Nancy, France
[11] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA USA
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2023年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：256 / 256
页数：1
相关论文
共 50 条
  • [1] The Face of Diabetic Cardiomyopathy-Baseline Characteristics from the ARISE-HF Trial
    Butler, Javed
    Del Prato, Stefano
    Ezekowitz, Justin
    Ibrahim, Nasrien E.
    Lam, Carolyn S.
    Perfetti, Riccardo
    Rosenstock, Julio
    Tang, W. H. Wilson
    Urbinati, Alessia
    Zannad, Faiez
    Januzzi, James L.
    DIABETES, 2023, 72
  • [2] Characterizing diabetic cardiomyopathy: baseline results from the ARISE-HF trial
    James L. Januzzi
    Stefano Del Prato
    Julio Rosenstock
    Javed Butler
    Justin Ezekowitz
    Nasrien E. Ibrahim
    Carolyn S.P. Lam
    Thomas Marwick
    W. H. Wilson Tang
    Yuxi Liu
    Reza Mohebi
    Alessia Urbinati
    Faiez Zannad
    Riccardo Perfetti
    Cardiovascular Diabetology, 23
  • [3] Characterizing diabetic cardiomyopathy: baseline results from the ARISE-HF trial
    Januzzi, James L.
    Del Prato, Stefano
    Rosenstock, Julio
    Butler, Javed
    Ezekowitz, Justin
    Ibrahim, Nasrien E.
    Lam, Carolyn S. P.
    Marwick, Thomas
    Tang, W. H. Wilson
    Liu, Yuxi
    Mohebi, Reza
    Urbinati, Alessia
    Zannad, Faiez
    Perfetti, Riccardo
    CARDIOVASCULAR DIABETOLOGY, 2024, 23 (01)
  • [4] Racial Differences in Diabetic Cardiomyopathy The ARISE-HF Trial
    Lopez, Jose
    Liu, Yuxi
    Butler, Javed
    Del Prato, Stefano
    Ezekowitz, Justin A.
    Lam, Carolyn S. P.
    Marwick, Thomas H.
    Rosenstock, Julio
    Tang, W. H. Wilson
    Perfetti, Riccardo
    Urbinati, Alessia
    Zannad, Faiez
    Januzzi, James L.
    Ibrahim, Nasrien E.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 84 (03) : 233 - 243
  • [5] Physical Activity Levels And Cardiac Functional Capacity In Patients With Diabetic Cardiomyopathy: Baseline Analysis From The Arise-HF Trial
    Butler, Javed
    Del Prat, Stefano
    Ezekowitz, Justin
    Ibrahim, Nasrien
    Lams, Carolyn
    Marwick, Thomas
    Perfetti, Ricardo
    Rosenstock, Julio
    Tangs, Wai Hong
    Urbinati, Alessia
    Zannad, Faiez
    Januzzi, James
    JOURNAL OF CARDIAC FAILURE, 2024, 30 (01) : 310 - 310
  • [6] NT-proBNP levels in diabetic cardiomyopathy: results from the ARISE-HF trial
    Butler, J.
    Tang, W. H. Wilson
    Lam, C.
    Del Prato, S.
    Ezekowitz, J.
    Ibrahim, N.
    Marwick, T.
    Perfetti, R.
    Rosenstock, J.
    Urbinati, A. Alessia
    Zannad, F.
    Januzzi, J.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 141 - 141
  • [7] Selective aldose reductase inhibition as a treatment for diabetic cardiomyopathy: summary of the ARISE-HF trial
    Khan, Laibah Arshad
    Khan, Muhammad Shahzeb
    Ambrosy, Andrew P.
    Greene, Stephen J.
    HEART FAILURE REVIEWS, 2024, 29 (05) : 1157 - 1160
  • [8] N-Terminal Pro-B Type Natriuretic Peptide Concentrations in Diabetic Cardiomyopathy-Baseline Data from the ARISE-HF Trial
    Butler, Javed
    Del Prato, Stefano
    Ezekowitz, Justin
    Ibrahim, Nasrien E.
    Lam, Carolyn S.
    Perfetti, Riccardo
    Rosenstock, Julio
    Tang, W. H. Wilson
    Urbinati, Alessia
    Zannad, Faiez
    Januzzi, James L., Jr.
    DIABETES, 2023, 72
  • [9] The ARISE-HF study: development of AT-001 for the treatment of diabetic cardiomyopathy: rationale and study design
    Ibrahim, N.
    Januzzi, J.
    Perfetti, R. P.
    Lawson, F.
    Shendelman, S.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 177 - 177
  • [10] Rationale and design of the Aldose Reductase Inhibition for Stabilization of Exercise Capacity in Heart Failure Trial (ARISE-HF) in patients with high-risk diabetic cardiomyopathy
    Januzzi Jr, James L.
    Butler, Javed
    Del Prato, Stefano
    Ezekowitz, Justin A.
    Ibrahim, Nasrien E.
    Lam, Carolyn S. P.
    Lewis, Gregory D.
    Marwick, Thomas H.
    Rosenstock, Julio
    Tang, W. H. Wilson
    Zannad, Faiez
    Lawson, Francesca
    Perfetti, Riccardo
    Urbinati, Alessia
    AMERICAN HEART JOURNAL, 2023, 256 : 25 - 36
12345